retatrutide clinical trial phase retatrutide Eli Lilly's 3 studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments Will Reta Rewrite Obesity? -

Fierce: Fuchsia

Agonist Use With Risk of Gallbladder and Biliary Diseases

Chest pain or irregular heartbeat These could indicate stress on the cardiovascular system and require urgent evaluation

How GLP-1 Medications Might Impact Oral Health Symptoms to Watch For Protecting Your Oral Health While Taking GLP-1 Medications Schedule A Dental Visit In Greeley FAQs Key Takeaway GLP-1 medications may lead to changes in oral health, including dry mouth, enamel erosion, or gum irritation

Clinical trials show non-diabetic individuals lose an average of 1022% of body weight over one year, with results varying based on genetics, starting weight, and lifestyle support